Rebecca Taub - Net Worth and Insider Trading
Rebecca Taub Net Worth
The estimated net worth of Rebecca Taub is at least $228 Million dollars as of 2024-04-30. Rebecca Taub is the Pres., R&D, and CMO of Madrigal Pharmaceuticals Inc and owns about 1,114,539 shares of Madrigal Pharmaceuticals Inc (MDGL) stock worth over $228 Million. Details can be seen in Rebecca Taub's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Rebecca Taub has not made any transactions after 2024-04-08 and currently still holds the listed stock(s).
Transaction Summary of Rebecca Taub
Rebecca Taub Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rebecca Taub owns 3 companies in total, including Madrigal Pharmaceuticals Inc (MDGL) , VIA Pharmaceuticals Inc (VIAP) , and BriaCell Therapeutics Corp (BCTX) .
Click here to see the complete history of Rebecca Taub’s form 4 insider trades.
Insider Ownership Summary of Rebecca Taub
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MDGL | Madrigal Pharmaceuticals Inc | 2024-04-08 | director & Chief Medical Officer & EVP R&D |
| VIAP | VIA Pharmaceuticals Inc | 2008-12-05 | SVP & Research & Development |
| BCTX | BriaCell Therapeutics Corp | 2022-08-01 | director |
Rebecca Taub Latest Holdings Summary
Rebecca Taub currently owns a total of 1 stock. Rebecca Taub owns 1,114,539 shares of Madrigal Pharmaceuticals Inc (MDGL) as of April 8, 2024, with a value of $228 Million.
Latest Holdings of Rebecca Taub
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MDGL | Madrigal Pharmaceuticals Inc | 2024-04-08 | 1,114,539 | 204.35 | 227,756,045 |
Holding Weightings of Rebecca Taub
Rebecca Taub Form 4 Trading Tracker
According to the SEC Form 4 filings, Rebecca Taub has made a total of 2 transactions in Madrigal Pharmaceuticals Inc (MDGL) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Madrigal Pharmaceuticals Inc is the sale of 2,676 shares on April 8, 2024, which brought Rebecca Taub around $658,269.
Insider Trading History of Rebecca Taub
- 1
Rebecca Taub Trading Performance
Rebecca Taub Ownership Network
Ownership Network List of Rebecca Taub
Ownership Network Relation of Rebecca Taub
Rebecca Taub Owned Company Details
What does Madrigal Pharmaceuticals Inc do?
Who are the key executives at Madrigal Pharmaceuticals Inc?
Rebecca Taub is the director & Chief Medical Officer & EVP R&D of Madrigal Pharmaceuticals Inc. Other key executives at Madrigal Pharmaceuticals Inc include director & Chief Executive Officer Paul A Friedman , Senior VP & Chief Pharma Dev. Robert E. Waltermire , and SVP and General Counsel Brian Joseph Lynch .
Madrigal Pharmaceuticals Inc (MDGL) Insider Trades Summary
Over the past 18 months, Rebecca Taub made 2 insider transaction in Madrigal Pharmaceuticals Inc (MDGL) with a net sale of 76,564. Other recent insider transactions involving Madrigal Pharmaceuticals Inc (MDGL) include a net purchase of 424,685 shares made by Baker Bros. Advisors Lp , a net sale of 29,800 shares made by Brian Joseph Lynch , and a net sale of 100,000 shares made by Paul A Friedman .
In summary, during the past 3 months, insiders sold 252,542 shares of Madrigal Pharmaceuticals Inc (MDGL) in total and bought 0 shares, with a net sale of 252,542 shares. During the past 18 months, 342,631 shares of Madrigal Pharmaceuticals Inc (MDGL) were sold and 424,685 shares were bought by its insiders, resulting in a net purchase of 82,054 shares.
Madrigal Pharmaceuticals Inc (MDGL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Madrigal Pharmaceuticals Inc Insider Transactions
Rebecca Taub Mailing Address
Above is the net worth, insider trading, and ownership report for Rebecca Taub. You might contact Rebecca Taub via mailing address: 750 Battery Street, Suite 330, San Francisco Ca 94111.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
